BRIEF published on 10/14/2026 at 17:50, 24 days 15 hours ago Eyonis Inc. unveils promising results from eyonis® LCS at CHEST 2026 FDA Artificial Intelligence Lung Cancer Screening Eyonis® LCS CHEST 2026
BRIEF published on 10/14/2026 at 17:50, 24 days 15 hours ago Eyonis Inc. to Showcase AI in Lung Cancer Detection at CHEST 2026 AI In Healthcare Lung Cancer Screening Eyonis® LCS CHEST 2026 FDA-Cleared Technology
BRIEF published on 10/14/2026 at 17:50, 24 days 15 hours ago Eyonis Inc. dévoile les résultats prometteurs d'eyonis® LCS à CHEST 2026 FDA Intelligence Artificielle Eyonis® LCS Dépistage Cancer Poumon CHEST 2026
PRESS RELEASE published on 10/14/2026 at 17:45, 24 days 15 hours ago Inside Information / Other news releases eyonis Inc. to present study results supporting eyonis® LCS performance claims at CHEST 2026. Key insights into AI/ML-based Software as a Medical Device for lung cancer screening. Importance of pulmonologists in adoption Eyonis® LCS CHEST 2026 Eyonis Inc. Pulmonologists AI-enabled Decision Support
PRESS RELEASE published on 10/14/2026 at 17:45, 24 days 15 hours ago Informations privilégiées / Autres communiqués eyonis Inc., filiale de Median Technologies, présentera les performances de eyonis® LCS à CHEST 2026, démontrant une sensibilité de 93,3%, une spécificité de 92,4% et une valeur prédictive négative de 99,9% Median Technologies Eyonis® LCS Dépistage Cancer CHEST 2026 Eyonis Inc.
BRIEF published on 09/15/2026 at 17:50, 1 month 22 days ago Median Technologies Secures Major €8.4 Million iCRO Project AI-powered Solutions Phase III Trial ICRO Project Oncology Imaging Global Pharmaceutical
BRIEF published on 09/15/2026 at 17:50, 1 month 22 days ago Median Technologies décroche un important projet iCRO de 8,4 millions d'euros. Solutions Basées Sur L'IA Essai De Phase III Projet ICRO Imagerie En Oncologie Industrie Pharmaceutique Mondiale
PRESS RELEASE published on 09/15/2026 at 17:45, 1 month 22 days ago Inside Information / Other news releases Median Technologies secures an €8.4 million global phase III oncology imaging project, expanding its iCRO order backlog and revenue visibility. Project awarded by a leading European pharmaceutical company for brain cancer study Pharmaceutical Company Median Technologies Global Project ICRO Oncology Imaging
BRIEF published on 09/08/2026 at 19:50, 1 month 29 days ago Median Technologies: Information on voting rights and capital Share Capital Voting Rights Treasury Shares Financial Market Median Technologies
BRIEF published on 09/08/2026 at 19:50, 1 month 29 days ago Median Technologies' Voting Rights and Capital Structure as of August 2026 Voting Rights Warrants Shares Capital Structure Median Technologies
Published on 11/06/2026 at 22:15, 1 day 11 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 21 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 21 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 19 hours 59 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 1 day 13 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 1 day 13 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:15, 1 day 14 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day 14 hours ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 19:06, 1 day 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 1 day 14 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 1 day 14 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 1 day 14 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
